- Home
- Unlocking the immune system
Unlocking the immune system
Our bodies have the amazing capacity to heal when stimulated or activated properly. At Johnson & Johnson, we are advancing scientific and technological solutions that accelerate healing, recalibrate, or modify the body’s own immune system so it is best equipped to heal. By unlocking the complex science of the immune system, our discoveries are changing lives.
Innovating in Health&Care
Are super-personalized solutions the future of healthcare?
The goal of precision medicine is to develop individualized treatments based on a patient’s genetic profile. Here’s how Johnson & Johnson is harnessing this cutting-edge field of tailor-made medicine.
Getting in front of cancer
Every year, roughly 2 million people in the U.S. are newly diagnosed with cancer. But a number of scientific breakthroughs—including ones made at Johnson & Johnson—have dramatically changed what kind of prognosis many of these patients will have.
What is IL-23?
This pro-inflammatory protein is the target of potential Johnson & Johnson medications that could help treat autoimmune conditions such as psoriasis, inflammatory bowel disease and rheumatoid arthritis.
IBD rates are rising in communities of color. Can these innovators help?
Scientists aren’t sure what’s behind the upward trend. That’s why Johnson & Johnson Innovation put out the call to address this troubling health disparity.
Rheumatoid, psoriatic and osteoarthritis—what you need to know about the 3 main types of arthritis
They share similar symptoms, sure. But these three distinct conditions have distinct causes, occur in people of varying ages and have their own treatments. Read on for the key differences.
What is low vision?
Low vision isn’t the same as blindness, but navigating daily life with it is still challenging. Learn the facts—plus, the promising treatment innovations that are in the works.
More from Johnson & Johnson
What you need to know about Johnson & Johnson’s 2024 fourth-quarter and full-year earnings report
Check out this infographic breakdown of the company’s fourth-quarter and full-year performance, with highlights from its Innovative Medicine and MedTech businesses.
5 things we now know about eczema (a.k.a., atopic dermatitis)
The most common inflammatory skin disease causes scaly patches, blisters and severe itching, but it’s far more than just a cosmetic concern. Learn why Johnson & Johnson is focused on helping the millions living with this painful condition.
Terra Kremer, Ph.D., is on a mission to create self-sterilizing surgical tools
Since its launch, Johnson & Johnson has focused on helping make surgeries safer. Learn how this analytical microbiologist and her team are continuing in that tradition with a digital app that aims to change the way medical devices are designed and sterilized.